FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
Simplexa Flu A/B & RSV Direct Gen II, Simplexa Flu A/B & RSV Positive Control Pack
K Number: K201505
·
Decision Aug 22, 2020
Classifications
1
FEI Numbers
29
Registration Numbers
29
Same Product Code
77
Applicant Total
11
Review Days
78
Basic Information
- Device Name
- Simplexa Flu A/B & RSV Direct Gen II, Simplexa Flu A/B & RSV Positive Control Pack
- K Number
- K201505
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 866.3980
- Medical Specialty
- Microbiology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- DiaSorin Molecular LLC
- Date Received
- June 5, 2020
- Decision Date
- August 22, 2020
- Product Code
- OCC
- Advisory Committee
- Microbiology
- Review Advisory Committee
- MI
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| OCC | Respiratory Virus Panel Nucleic Acid Assay System | FDA class 2 | Microbiology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (OCC), ordered by most recent decision date.
NxTAG® Respiratory Pathogen Panel
FDA 510(k)
FDA Class 2
·Microbiology
ID NOW Influenza A & B 2
FDA 510(k)
FDA Class 2
·Microbiology
Panther Fusion AdV/hMPV/RV Assay
FDA 510(k)
FDA Class 2
·Microbiology
cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System
FDA 510(k)
FDA Class 2
·Microbiology
cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat System
FDA 510(k)
FDA Class 2
·Microbiology
cobas Influenza A/B Nucleic acid test for use on the cobas Liat System, cobas Influenza A/B & RSV Nucleic acid test for use on the cobas Liat System, cobas Strep A Nucleic acid test for use on the cobas Liat System
FDA 510(k)
FDA Class 2
·Microbiology
Other Clearances by DiaSorin Molecular LLC
| K Number | Device Name | ||
|---|---|---|---|
| DEN230092 | Simplexa C. auris Direct, Simplexa C. auris Positive Control Pack, Simplexa C. auris Sample Prep Kit (MOL3950, MOL3960, MOL5390) | Jul 15, 2024 | Unknown |
| K220963 | Simplexa COVID-19 & Flu A/B Direct | Mar 17, 2023 | Substantially Equivalent |
| K202755 | Simplexa Congenital CMV Direct and Simplexa Congenital CMV Positive Control Pack | Nov 5, 2022 | Substantially Equivalent |
| K212147 | Simplexa COVID-19 Direct | Sep 13, 2022 | Substantially Equivalent |
| K192376 | Simplexa VZV Swab Direct, Simplexa VZV Positive Control Pack | Nov 26, 2019 | Substantially Equivalent |
| K190219 | Simplexa VZV Direct, Simplexa VZV Positive Control Pack | May 13, 2019 | Substantially Equivalent |
| K183223 | Simplexa Bordetella Direct, Simplexa Bordetella Positive Control Pack | Dec 19, 2018 | Substantially Equivalent |
| K182467 | Simplexa GBS Direct, Simplexa GBS Positive Control Pack | Nov 7, 2018 | Substantially Equivalent |
| K173498 | Simplexa Bordetella Direct, Simplexa Bordetella Positive Control Pack | Aug 13, 2018 | Substantially Equivalent |
| K173798 | Simplexa HSV 1 & 2 Direct, Simplexa HSV 1 & 2 Positive Control Pack | Mar 14, 2018 | Substantially Equivalent |